Human P2X7 pore function predicts allele linkage disequilibrium

Clinical Chemistry

Volumn 52, Issue 6, 2006, Pages 995-1004

  Denlinger, Loren C ^a   Coursin, Douglas B ^a   Schell, Kathleen ^b   Angelini, Giuditta ^a   Green, Dawn N ^a   Guadarrama, Arturo G ^a   Halsey, Jennifer ^a   Prabhu, Usha ^a   Hogan, Kirk J ^a   Bertics, Paul J ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; PURINE P2X7 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; PURINE P2 RECEPTOR;

ALLELISM; ARTICLE; CHANNEL GATING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; LINKAGE ANALYSIS; NORMAL HUMAN; PHENOTYPE; PREDICTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ALLELE; BLOOD; GENETICS; METABOLISM; MONOCYTE; NUCLEAR PORE; PHYSIOLOGY; PREDICTION AND FORECASTING; PROBABILITY; ROC CURVE; ULTRASTRUCTURE;

ALLELES; BIOLOGICAL MARKERS; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MONOCYTES; NUCLEAR PORE; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREDICTIVE VALUE OF TESTS; PROBABILITY; RECEPTORS, PURINERGIC P2; ROC CURVE;

EID: 33646924818     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.065425     Document Type: Article

References (49)

1. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 1996;272:735-8.
2. Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001;97:587-600.
3. la Sala A, Ferrari D, Di Virgilio F, Idzko M, Norgauer J, Girolomoni G. Alerting and tuning the immune response by extracellular nucleotides. J Leukoc Biol 2003;73:339-43.
4. Beigi R, Kobatake E, Aizawa M, Dubyak GR. Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am J Physiol 1999;276:C267-78.
5. Gudipaty L, Humphreys BD, Buell G, Dubyak GR. Regulation of P2X(7) nucleotide receptor function in human monocytes by extracellular ions and receptor density. Am J Physiol 2001;280: C943-53.
6. Smart ML, Panchal RG, Bowser DN, Williams DA, Petrou S. Pore formation is not associated with macroscopic redistribution of P2X7 receptors. Am J Physiol 2002;283:C77-84.
7. Watters JJ, Sommer JA, Fisette PL, Pfeiffer ZA, Aga M, Prabhu U, et al. The P2X7 nucleotide receptor: Mmodulation of LPS-induced macrophage signaling and mediator production. Drug Dev Res 2001;53:91-104.
8. Tonetti M, Sturla L, Giovine M, Benatti U, De Flora A. Extracellular ATP enhances mRNA levels of nitric oxide synthase and TNF-α In lipopolysaccharide-treated RAW 264.7 murine macrophages. Biochem Biophys Res Commun 1995;214:125-30.
9. Perregaux DG, McNiff P, Laliberte R, Conklyn M, Gabel CA. ATP acts as an agonist to promote stimulus-induced secretion of IL-1β and IL-18 in human blood. J Immunol 2000;165:4615-23.
10. Hu Y, Fisette PL, Denlinger LC, Guadarrama AG, Sommer JA, Proctor RA, et al. Purinergic receptor modulation of lipopolysaccharide signaling and inducibie nitric-oxide synthase expression in RAW 264.7 macrophages. J Biol Chem 1998;273:27170-5.
11. Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, Koller BH, et al. Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 2001;276:125-32.
12. Sluyter R, Shemon AN, Wiley JS. Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1b release from human monocytes. J Immunol 2004;172:3399-405.
13. Sluyter R, Dalitz JG, Wiley JS. P2X7 receptor polymorphism impairs extracellular adenosine 5′-triphosphate-induced interleukin-18 release from human monocytes. Genes Immun 2004;5:588-91.
14. Saunders BM, Fernando SL, Sluyter R, Britton WJ, Wiley JS. A loss-of-function polymorphism in the human P2X7 receptor abolishes ATP-mediated killing of mycobacteria. J Immunol 2003;171:5442-6.
15. Fernando SL, Saunders BM, Sluyter R, Skarratt KK, Wiley JS, Britton WJ. Gene dosage determines the negative effects of polymorphic alleles of the P2X7 receptor on adenosine triphosphate-mediated killing of mycobacteria by human macrophages. J Infect Dis 2005;192:149-55.
16. Coutinho-Silva R, Perfettini JL, Persechini PM, Dautry-Varsat A, Ojcius DM- Modulation of P2Z/P2X(7) receptor activity in macrophages infected with Chlamydia psittaci. Am J Physiol 2001;280: C81-9.
17. Coutinho-Silva R, Stahl L, Raymond MN, Jungas T, Verbeke P, Burnstock G, et al. Inhibition of chlamydial infectious activity due to P2X7R-dependent phospholipase D activation. Immunity 2003;19:403-12.
18. Buell GN, Talabot F, Gos A, Lorenz J, Lai E, Morris MA, et al. Gene structure and chromosomal localization of the human P2X7 receptor. Receptors Channels 1998;5:347-54.
19. National Center for Biotechnology Information. SNP database. http://www.ncbi.nlm.nih.gov/entrez/ (accessed February 15, 2006).
20. Gu BJ, Zhang W, Worthington RA, Sluyter R, Dao-Ung P, Petrou S, et al. A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J Biol Chem 2001;276:11135-42.
21. Wiley JS, Dao-Ung LP, Li C, Shemon AN, Gu BJ, Smart ML, et al. An lle-568 to Asn polymorphism prevents normal trafficking and function of the human P2X7 receptor. J Biol Chem 2003;278:17108-13.
22. Gu BJ, Sluyter R, Skarratt KK, Shemon AN, Dao-Ung LP, Fuller SJ, et al. An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor. J Biol Chem 2004;279:31287-95.
23. Cabrini G, Falzoni S, Forchap SL, Pellegatti P, Balboni A, Agostini P, et al. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. J Immunol 2005;175:82-9.
24. Wiley JS, Dao-Ung LP, Gu BJ, Sluyter R, Shemon AN, Li C, et al. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet 2002;359:1114-9.
25. Thunberg U, Tobin G, Johnson A, Soderberg O, Padyukov L, Hultdin M. et al. Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia. Lancet 2002;360:1935-9.
26. Dao-Ung LP, Fuller SJ, Sluyter R, SkarRatt KK, Thunberg U, Tobin G, et al. Association of the 1513C polymorphism in the P2X7 gene with familial forms of chronic lymphocytic leukaemia. Br J Haematol 2004;125:815-7.
27. Li CM, Campbell SJ, Kumararatne DS, Bellamy R, Ruwende C, McAdam KP, et al. Association of a polymorphism in the P2X7 gene with tuberculosis in a Gambian population. J Infect Dis 2002;186:1458-62.
28. Zhang LY, Ibbotson RE, Orchard JA, Gardiner AC, Seear RV, Chase AJ, et al. P2X7 polymorphism and chronic lymphocytic leukaemia: lack of correlation with incidence, survival and abnormalities of chromosome 12. Leukemia 2003;17:2097-100.
29. Li CM, Campbell SJ, Kumararatne DS, Hill AV, Lammas DA. Response heterogeneity of human macrophages to ATP is associated with P2X7 receptor expression but not to polymorphisms in the P2RX7 promoter. FEBS Lett 2002;531:127-31.
30. Denlinger LC, Schell K, Angelini G, Green D, Guadarrama A, Prabhu U, et al. A novel assay to detect nucleotide receptor P2X7 genetic polymorphisms influencing numerous innate immune functions. J Endotoxin Res 2004;10:137-42.
31. Denlinger LC, Angelini G, Schell K, Green DN, Guadarrama AG, Prabhu U, et al. Detection of human P2X7 nucleotide receptor polymorphisms by a novel monocyte pore assay predictive of alterations in lipopolysaccharide-induced cytokine production. J Immunol 2005;174:4424-31.
32. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994;271:703-7.
33. Ding K, Zhou K, He F, Shen Y. LDA-a JAVA-based linkage disequilibrium analyzer. Bioinformatics 2003;19:2147-8.
34. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003;73:1162-9.
35. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-89.
36. Feng Z, Prentice R, Srivastava S. Research issues and strategies for genomic and proteomic biomarker discovery and validation: a statistical perspective. Pharmacogenomics 2004;5:709-19.
37. Mizuno K, Okamoto H, Horio T. Heightened ability of monocytes from sarcoidosis patients to form multi-nucleated giant cells in vitro by supernatants of concanavalin A-stimulated mononuclear cells. Clin Exp Immunol 2001;126:151-6.
38. Elliott Jl, Higgins CF. Major histocompatibility complex class 1 shedding and programmed cell death stimulated through the proinflammatory P2X7 receptor, a candidate susceptibility gene for NOD diabetes. Diabetes 2004;53:2012-7.
39. Mueller JC. Linkage disequilibrium for different scales and applications. Brief Bioinform 2004;5:355-64.
40. Chessell IP, Simon J, Hibell AD, Michel AD, Barnard EA, Humphrey PP. Cloning and functional characterisation of the mouse P2X7 receptor. FEBS Lett 1998;439:26-30.
41. Skarratt KK, Fuller SJ, Sluyter R, Dao-Ung LP, Gu BJ, Wiley JS. A 5′ intronic splice site polymorphism leads to a null allele of the P2X7 gene in 1-2% of the Caucasian population. FEBS Lett 2005;579:2675-8.
42. Denlinger LC, Fisette PL, Sommer JA, Watters JJ, Prabhu U, Dubyak GR, et al. Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J Immunol 2001;167:1871-6.
43. Denlinger LC, Sommer JA, Parker K, Gudipaty L, Fisette PL, Watters JJ, et al. Mutation of a dibasic amino acid motif within the C-terminus of the P2X7 nucleotide receptor results in trafficking defects and impaired function. J Immunol 2003;171:1304-11.
44. Smart ML, Gu B, Panchal RG, Wiley J, Cromer B, Williams DA, et al. P2X7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region. J Biol Chem 2003;278:8853-60.
45. Kochukov MY, Ritchie AK. A P2X7 receptor stimulates plasma membrane trafficking in the FRTL rat thyrocyte cell line. Am J Physiol 2004;287:C992-1002.
46. Kim M, Jiang LH, Wilson HL, North RA, Surprenant A. Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J 2001;20:6347-58.
47. Pizarro-Cerda J, Cossart P. Subversion of phosphoinositide metabolism by intraceilular bacterial pathogens. Nat Cell Biol 2004;6:1026-33.
48. Olobo JO, Geletu M, Demissie A, Eguale T, Hiwot K, Aderaye G, et al. Circulating TNF-α, TGF-β, and IL-10 in tuberculosis patients and healthy contacts. Scand J Immunol 2001;53:85-91.
49. Geng Y, Shane RB, Berencsi K, Gonczol E, Zaki MH, Margolis DJ, et al. Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10. J Immunol 2000;164:5522-9.